Loading...
 
Mediterr J Rheumatol 2022;33(2):232-6
The Impact of Colchicine on COVID-19 patients: A Clinical Trial Study
Authors Information

1Pediatric Department, Bouali Children`s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran

2Department of Community Medicine, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran

3Pediatric Department, Bouali Children’s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran

F Salehzadeh

Keywords: COVID-19, colchicine
References
  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle [published January 16, 2020].  J Med Virol 2020 Apr;92(4):401-2.
  2. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel corona cytokine virus outbreak in Wuhan, China [published January 14, 2020].  Int J Infect Dis 2020;91:264-66.
  3. Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989.
  4. World Health Organization. Coronavirus disease (COVID-19): situation report. Accessed August 16, 2020.
  5. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200817-weekly-epi-update-1.pdf?sfvrsn=b6d49a76_4
  6. Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med 2020;217(6).
  7. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033-4.
  8. Vitiello A, Ferrara F, Pelliccia C, Granata G, La Porta R. Cytokine storm and colchicine potential role fighting SARS-CoV-2 pneumonia. Ital J Med 2020;14(2):88-94.
  9. Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 2016;8(8):959‐970.
  10. Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 2020:105954.
  11. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Microbiol Mol Biol Rev Mar 2012;76(1):16-32.
  12. Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine. Rheumatology 2017;57(Suppl 1) i4–i11.
  13. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
  14. Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020;20(4):398-400.
  15. Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R role in treatment of COVID-19-related ARDS. J Transl Med 2020;18:5.
  16. Martínez GJ, Robertson S, Barraclough J, Xia Q, Mallat Z, Bursill C, et al. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome. J Am Heart Assoc 2015 Aug 24;4(8):e002128.
  17. Robertson S, Martínez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, et al. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci (Lond) 1 July 2016;130 (14):1237-46.
  18. Gautret P, Lagier JC, Parola P, Hoang Thuan V, Meddeb L, Maihe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents 2020;105949.
  19. Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, et al. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open 2020;3(6):e2013136.
  20. Mansouri N, Marjani M, Tabarsi P, von Garnier C, Mansouri D. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature, Immunological Investigations. Immunol Invest 2021 Nov;50(8):884-90.